Sleep-Wake Disorders. Sleep Disorders
Conditions
Interventions
Intervention 1: Intervention group: Transdiagnostic Sleep and Circadian Intervention (TranS-C) consists of three sets of modules: four cross-cutting modules (Case Formulation, Sleep andCircadian Educa
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
22 Years to 60 Years
Inclusion criteria
Inclusion criteria: Aged 22-60 years Having One or more of the following sleep or circadian problems for 3 months: =30 minutes to get to sleep on three or more nights per week, Waking in the middle of the night for=30 minutes on three or more nights per week, Obtaining <6 h of sleep per night on three or more nights per week. Obtaining more than 9 hours of sleep per 24 hour period (i.e., nighttime sleep plus daytime napping), 3 or more nights per week, More than 2.78 h of variability in sleep-wake schedule across 1 week, Bedtime later than 2:00 a.m. on three or more nights per week Having adequate opportunity to sleep.
Exclusion criteria
Exclusion criteria: Meeting DSM–5 criteria for one of major mental disorder including schizophrenia, bipolar disorder, sever major depression disorder based on SCID Meeting DSM–5 criteria for one of other sleep-wake disorder including narcolepsy, nightmare disorder, restless legs syndrome, breathing-related sleep disorders, non-REM (NREM) sleep arousal disorders, REM sleep behavior disorder, and substance-or medication-induced sleep disorder, based on SCID Having serious suicidal ideation Change in the type and dosage of psychiatric drugs used during the psychotherapy period Absence of more than 3 sessions in psychotherapy Having night shifitwork
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep and Circadian Problems. Timepoint: Before and after interventions and three month follow-up. Method of measurement: Daily Sleep Dairy, Patient-Reported Outcomes Measurement Information System (PROMIS™) Sleep Disturbance (SD) Patient-Reported Outcomes Measurement Information System (PROMIS™) Sleep-Related Impairment (SRI).;Sleep Quality. Timepoint: Before and after interventions and three month follow-up. Method of measurement: Pittsburgh Sleep Quality Index.;Insomnia Severity. Timepoint: Before and after interventions and three month follow-up. Method of measurement: Insomnia Severity Index.;Fatigue. Timepoint: Before and after interventions and three month follow-up. Method of measurement: Fatigue Severity Scale.;Sleepiness. Timepoint: Before and after interventions and three month follow-up. Method of measurement: Epworth sleepiness scale.;Morningness-Eveningness. Timepoint: Before and after interventions and three month follow-up. Method of measurement: Morningness-Eveningness Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Depression symptom severity. Timepoint: Before and after interventions and three month follow-up. Method of measurement: Hospital Anxiety Depression Scale.;Anxiety symptom severity. Timepoint: Before and after interventions and three month follow-up. Method of measurement: Hospital Anxiety Depression Scale.;Dysfunction. Timepoint: Before and after interventions and three month follow-up. Method of measurement: Sheehan Disability Scale.;Expectation of therapy. Timepoint: Before and after interventions. Method of measurement: Expectation of therapy interview.;Experience of therapy. Timepoint: Before and after interventions. Method of measurement: Experience of therapy interview. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFahime AhmadianVargahan
Iran University of Medical Sciences
Outcome results
None listed